Utility of adjuvant immunotherapy in high-risk non-metastatic renal cell carcinoma: A real-world experience using national cancer database analysis

被引：0
|
作者：
Garg, H. [1 ]
Bhandari, M. [2 ]
Noel, O. V. [1 ]
Dursun, F. [1 ]
Liss, M. A. [1 ]
Kaushik, D. [1 ]
Ramamurthy, C. [3 ]
Mansour, A. M. [1 ]
机构：
[1] Univ Texas Hlth San Antonio, Dept Urol, San Antonio, TX USA
[2] Univ Texas Hlth San Antonio, Dept Populat Hlth Sci, San Antonio, TX USA
[3] Univ Texas Hlth San Antonio, Dept Med Oncol, San Antonio, TX USA
来源：
EUROPEAN UROLOGY | 2023年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0475
引用
收藏
页码：S678 / S679
页数：2
相关论文
共 50 条
  • [21] The Role of Adjuvant Chemotherapy in Non-Metastatic Goblet Cell Carcinoid of the Appendix: An 11-Year Experience from the National Cancer Database
    AlMasri, Samer
    Nassour, Ibrahim
    Kowalsky, Stacy J.
    Hrebinko, Katherine
    Singhi, Aatur D.
    Lee, Kenneth K.
    Choudry, Haroon A.
    Bartlett, David
    Zureikat, Amer
    Paniccia, Alessandro
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (07) : 3873 - 3881
  • [22] The Role of Adjuvant Chemotherapy in Non-Metastatic Goblet Cell Carcinoid of the Appendix: An 11-Year Experience from the National Cancer Database
    Samer AlMasri
    Ibrahim Nassour
    Stacy J. Kowalsky
    Katherine Hrebinko
    Aatur D. Singhi
    Kenneth K. Lee
    Haroon A. Choudry
    David Bartlett
    Amer Zureikat
    Alessandro Paniccia
    Annals of Surgical Oncology, 2021, 28 : 3873 - 3881
  • [23] REAL-WORLD EFFECTIVENESS AND RACIAL/ETHNIC DISPARITIES IN IMMUNOTHERAPY FOR ADVANCED HEPATOCELLULAR CARCINOMA: ANALYSIS OF US NATIONAL CANCER DATABASE
    Ahn, Joseph C.
    Lauzon, Marie
    Luu, Michael
    Noureddin, Mazen
    Ayoub, Walid S.
    Kuo, Alexander
    Sundaram, Vinay
    Kosari, Kambiz
    Nissen, Nicholas N.
    Gong, Jun
    Hendifar, Andrew
    Roberts, Lewis R.
    Abou-Alfa, Ghassan K.
    Singal, Amit G.
    Yang, Ju Dong
    GASTROENTEROLOGY, 2022, 162 (07) : S1140 - S1140
  • [24] Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database
    Park, Changsu Lawrence
    Moria, Feras Ayman
    Ghosh, Sunita
    Wood, Lori
    Bjarnason, Georg A.
    Bhindi, Bimal
    Heng, Daniel Yick Chin
    Castonguay, Vincent
    Pouliot, Frederic
    Kollmannsberger, Christian K.
    Bosse, Dominick
    Basappa, Naveen S.
    Finelli, Antonio
    Fallah-rad, Nazanin
    Breau, Rodney H.
    Lalani, Aly-Khan A.
    Tanguay, Simon
    Graham, Jeffrey
    Saleh, Ramy R.
    CURRENT ONCOLOGY, 2024, 31 (08) : 4704 - 4712
  • [25] Utilization and Survival Benefit of Adjuvant Immunotherapy in Resected High-Risk Stage II Melanoma: A National Cancer Database Analysis
    Wong, W. G.
    Olecki, E.
    Stahl, K.
    Holguin, R. Perez
    Pameijer, C.
    Shen, C.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S27 - S27
  • [26] Real-world experience of second-line axitinib in metastatic renal cell carcinoma: analysis of the Swedish population
    Jakobsson, Maria
    Strambi, Angela
    Nilsson, Fredrik
    Arpegard, Johannes
    Dalen, Johan
    FUTURE ONCOLOGY, 2024, 20 (20) : 1385 - 1392
  • [27] Cost-utility of Sunitinib Versus Pazopanib in Metastatic Renal Cell Carcinoma in Canada using Real-world Evidence
    Sara Nazha
    Simon Tanguay
    Anil Kapoor
    Michael Jewett
    Christian Kollmannsberger
    Lori Wood
    G. A. Georg Bjarnason
    Daniel Heng
    Denis Soulières
    Martin Neil Reaume
    Naveen Basappa
    Eric Lévesque
    Alice Dragomir
    Clinical Drug Investigation, 2018, 38 : 1155 - 1165
  • [28] Cost-utility of Sunitinib Versus Pazopanib in Metastatic Renal Cell Carcinoma in Canada using Real-world Evidence
    Nazha, Sara
    Tanguay, Simon
    Kapoor, Anil
    Jewett, Michael
    Kollmannsberger, Christian
    Wood, Lori
    Bjarnason, G. A. Georg
    Heng, Daniel
    Soulieres, Denis
    Reaume, Martin Neil
    Basappa, Naveen
    Levesque, Eric
    Dragomir, Alice
    CLINICAL DRUG INVESTIGATION, 2018, 38 (12) : 1155 - 1165
  • [29] A retrospective multicenter characterization of patients with metastatic renal cell carcinoma: the Sicilian "real-world" experience
    Incorvaia, L.
    Badalamenti, G.
    Rizzo, S.
    Cicero, G.
    Rinaldi, G.
    Bazan, V.
    Marchese, A.
    Ancona, C.
    Piazza, D.
    Spada, M.
    Butera, A.
    Valenza, R.
    Blasi, L.
    Verderame, F.
    Adamo, V.
    Di Cristina, L.
    Borsellino, N.
    Savarino, A.
    Zerilli, F.
    Russo, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [30] A real-world experience of immune checkpoint inhibitors (ICI) in metastatic renal cell carcinoma (mRCC)
    Elias, Roy
    Levonyak, Nicholas
    Christie, Alana
    Bowman, Isaac Alexander
    Kapur, Payal
    Hannan, Raquibul
    Hammers, Hans J.
    Brugarolas, James
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
12345